These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 3716705

  • 61. The dexamethasone suppression test in psychotic disorders.
    Arana GW, Barreira PJ, Cohen BM, Lipinski JF, Fogelson D.
    Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
    [Abstract] [Full Text] [Related]

  • 62. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL, Nemeroff CB.
    J Psychiatr Res; 1987 Nov; 21(2):185-94. PubMed ID: 3585807
    [Abstract] [Full Text] [Related]

  • 63. Comparison of early and delayed inpatient dexamethasone suppression tests.
    Haskett RF, Zis AP, Albala AA, Lohr NE, Carroll BJ.
    Psychiatry Res; 1989 Feb; 27(2):161-71. PubMed ID: 2710864
    [Abstract] [Full Text] [Related]

  • 64. The dexamethasone suppression test in depression.
    Dam H, Mellerup ET, Rafaelsen OJ.
    J Affect Disord; 1985 Feb; 8(1):95-103. PubMed ID: 3156917
    [Abstract] [Full Text] [Related]

  • 65. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [Abstract] [Full Text] [Related]

  • 66. The diagnostic distribution of dexamethasone non-suppressors.
    Mellsop GW, Cooke RR, Vijayasenan ME.
    Aust N Z J Psychiatry; 1985 Jun; 19(2):168-71. PubMed ID: 3863606
    [Abstract] [Full Text] [Related]

  • 67. The specificity of the dexamethasone suppression test in endogenous depressive patients.
    Lu RB, Ho SL, Huang HC, Lin YT.
    Neuropsychopharmacology; 1988 May; 1(2):157-62. PubMed ID: 3251496
    [Abstract] [Full Text] [Related]

  • 68. The dexamethasone suppression test in psychotic versus non-psychotic endogenous depression.
    Rihmer Z, Arató M, Szádoczky E, Révai K, Demeter E, György S, Udvarhelyi P.
    Br J Psychiatry; 1984 Nov; 145():508-11. PubMed ID: 6498417
    [Abstract] [Full Text] [Related]

  • 69. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A, Frecska E, Rihmer Z, Arató M.
    Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
    [Abstract] [Full Text] [Related]

  • 70. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
    Carroll BJ, Feinberg M, Greden JF, Haskett RF, James NM, Steiner M, Tarika J.
    J Affect Disord; 1980 Sep; 2(3):177-94. PubMed ID: 6210723
    [Abstract] [Full Text] [Related]

  • 71. Diagnostic heterogeneity and the DST in consecutive psychiatric admissions.
    Keitner GI, Haier RJ, Qualls CB, Brown WA, McKendall MJ.
    Psychiatry Res; 1985 Mar; 14(3):215-23. PubMed ID: 3858894
    [Abstract] [Full Text] [Related]

  • 72. Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression.
    Orlikov AB, Prakhye IB, Ryzov IV.
    Biol Psychiatry; 1994 Jul 15; 36(2):97-102. PubMed ID: 7948450
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test.
    Pridmore S.
    Psychiatry Clin Neurosci; 1999 Feb 15; 53(1):33-7. PubMed ID: 10201281
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.